← Back to Articles
GLP-1 AGONISTS
Interruption of Early Cardiovascular Risk Pathways With GLP-1-Based Therapy for Obesity
Authors: Brendan M Everett, John W Ostrominski
Journal: Journal of the American College of Cardiology